- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-2-mer
- Ligands
- 20 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 40 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
NAG.21: 2 residues within 4Å:- Chain A: Y.15, N.48
Ligand excluded by PLIPNAG.22: 6 residues within 4Å:- Chain A: N.109, A.110, T.111, N.112, V.114, K.116
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain A: T.95, N.221, T.223
Ligand excluded by PLIPNAG.24: 1 residues within 4Å:- Chain A: N.269
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain A: N.318, Q.567, T.568
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain A: N.330, V.354, L.355
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain A: T.294, N.590
Ligand excluded by PLIPNAG.28: 1 residues within 4Å:- Chain A: N.603
Ligand excluded by PLIPNAG.29: 2 residues within 4Å:- Chain A: H.642, N.644
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain A: N.696, G.1118
- Chain B: D.783
Ligand excluded by PLIPNAG.31: 4 residues within 4Å:- Chain A: N.704, L.909, Q.913, Q.1058
Ligand excluded by PLIPNAG.32: 4 residues within 4Å:- Chain A: A.693, E.1059, K.1060, N.1061
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain A: N.151, N.152
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain B: N.603, T.605
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain B: H.642, V.643, N.644
Ligand excluded by PLIPNAG.36: 1 residues within 4Å:- Chain B: N.696
Ligand excluded by PLIPNAG.37: 4 residues within 4Å:- Chain B: N.704, N.906, L.909, Q.1058
Ligand excluded by PLIPNAG.38: 2 residues within 4Å:- Chain B: A.693, N.1061
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain A: R.344
- Chain B: N.152
Ligand excluded by PLIPNAG.40: 1 residues within 4Å:- Chain B: N.48
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain B: N.109, T.111, K.116
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain B: N.221, T.223
Ligand excluded by PLIPNAG.43: 3 residues within 4Å:- Chain A: K.545
- Chain B: E.268, N.269
Ligand excluded by PLIPNAG.44: 2 residues within 4Å:- Chain B: N.318, Q.567
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Chain B: N.330
Ligand excluded by PLIPNAG.46: 1 residues within 4Å:- Chain B: N.590
Ligand excluded by PLIPNAG.47: 2 residues within 4Å:- Chain C: Y.15, N.48
Ligand excluded by PLIPNAG.48: 4 residues within 4Å:- Chain C: N.109, T.111, N.112, V.114
Ligand excluded by PLIPNAG.49: 2 residues within 4Å:- Chain C: G.219, N.221
Ligand excluded by PLIPNAG.50: 2 residues within 4Å:- Chain C: N.267, N.269
Ligand excluded by PLIPNAG.51: 3 residues within 4Å:- Chain C: N.318, Q.567, T.568
Ligand excluded by PLIPNAG.52: 3 residues within 4Å:- Chain C: G.326, N.330, L.355
Ligand excluded by PLIPNAG.53: 1 residues within 4Å:- Chain C: N.590
Ligand excluded by PLIPNAG.54: 2 residues within 4Å:- Chain C: N.603, T.605
Ligand excluded by PLIPNAG.55: 2 residues within 4Å:- Chain C: H.642, N.644
Ligand excluded by PLIPNAG.56: 4 residues within 4Å:- Chain A: D.783
- Chain C: N.696, I.1117, G.1118
Ligand excluded by PLIPNAG.57: 3 residues within 4Å:- Chain C: E.1059, K.1060, N.1061
Ligand excluded by PLIPNAG.58: 2 residues within 4Å:- Chain C: E.119, N.152
Ligand excluded by PLIPNAG.59: 2 residues within 4Å:- Chain D: K.299, N.312
Ligand excluded by PLIPNAG.60: 2 residues within 4Å:- Chain E: K.299, N.312
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Xiao, T. et al., A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent. Nat.Struct.Mol.Biol. (2021)
- Release Date
- 2020-11-11
- Peptides
- Spike glycoprotein: ABC
Angiotensin-converting enzyme 2: DE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-2-mer
- Ligands
- 20 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 40 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Xiao, T. et al., A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent. Nat.Struct.Mol.Biol. (2021)
- Release Date
- 2020-11-11
- Peptides
- Spike glycoprotein: ABC
Angiotensin-converting enzyme 2: DE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E